![]() |
市场调查报告书
商品编码
1953953
物料搬运设备市场 - 全球产业规模、份额、趋势、机会及预测(按产品类型、应用、最终用户、地区和竞争格局划分,2021-2031年)Offloading Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球负载分配设备市场预计将从 2025 年的 110.1 亿美元成长到 2031 年的 152.8 亿美元,复合年增长率为 5.61%。
这些专用治疗设备旨在分散足底脆弱区域的压力,在糖尿病足溃疡的癒合和预防下肢截肢方面发挥关键作用。全接触式石膏、可拆卸式石膏步行器和改良鞋等设备透过将负重转移到足部健康区域,提供必要的保护。慢性代谢性疾病在全球范围内的日益普及推动了市场成长,而这与溃疡发生率的上升直接相关。根据国际糖尿病联盟 (IDF) 预测,到 2024 年,全球将有约 5.89 亿成年人患有糖尿病。不断扩大的患者群体,以及人口老化导致神经病变和周围血管疾病风险增加,共同推动了对有效压力调节疗法的持续需求。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 110.1亿美元 |
| 市场规模:2031年 | 152.8亿美元 |
| 复合年增长率:2026-2031年 | 5.61% |
| 成长最快的细分市场 | 糖尿病足溃疡的治疗 |
| 最大的市场 | 北美洲 |
然而,市场扩张的一大障碍是病患对处方机械减压通讯协定的依从性差。儘管临床疗效显着,但许多装置被患者认为笨重、活动受限或外观不佳,往往导致患者停止使用。这种依从性差的情况常常导致溃疡復发和復原时间延长,使临床疗效变得复杂。因此,这些挑战对严格的减压疗法在标准医疗流程中的广泛接受和实施产生了负面影响。
推动市场成长的关键因素是全球糖尿病和糖尿病足溃疡盛行率的不断上升。慢性高血糖会显着损害週边神经功能和血管健康,增加足底病变的风险。因此,透过机械减压降低峰值压力并促进组织修復至关重要。糖尿病患者发生溃疡的风险显着,凸显了这项临床需求。正如美国糖尿病协会于2024年12月发布的《2025年糖尿病护理标准》中所述,糖尿病患者一生中发生足溃疡的风险在19%至34%之间,这凸显了迫切需要有效的压力调节疗法来预防截肢等严重后果。
同时,肥胖导致的肌肉骨骼併发症发生率不断上升,进一步推动了对强效治疗方案的需求。超重会使足部结构承受超出其生理极限的压力,加速组织损伤并阻碍现有伤口的癒合。这个人口趋势蕴藏着巨大的市场潜力;根据世界肥胖联盟发布的《2024年世界肥胖地图集》(2024年3月发布),全球肥胖人口超过10亿。不断扩大的患者群体直接影响产业表现,製造商对承重设备的需求持续成长。例如,Osser公司于2024年1月发布的《2023年第四季中期报告》指出,其「矫正器具与支撑」部门(涵盖关键的承重技术)在2023财年实现了3%的有机销售成长,显示这些设备正稳步融入标准治疗通讯协定中。
全球减压装置市场成长的一大障碍是病患对处方机械减压通讯协定的依从性差。儘管这些装置对于压力重新分配至关重要,但其设计往往优先考虑功能性而非使用者舒适度,导致患者抵抗情绪严重。当患者觉得这些装置笨重或限制活动时,他们常常在疗程结束前就停止使用。这会干扰必要的组织修復,导致恢復时间延长和临床成功率降低。因此,这些装置的实际疗效远未达到其理论潜力,降低了人们对严格减压疗法的依赖,并对市场造成了影响。
低依从率会提高长期併发症发生率,从而阻碍市场发展,并使这些疗法在标准治疗方案中的经济效益难以论证。中断治疗导致的持续性伤口癒合失败会造成严重后果,对产品普及率产生负面影响。根据组织活力协会2024年的研究,糖尿病足溃疡癒合后的復发率介于6.2%至41.4%之间。这些数据凸显了设备处方与实际使用之间存在显着脱节,显示低依从性如何直接阻碍减压设备市场的有效推广和商业性扩张。
将智慧感测器技术整合到持续压力监测中,正在革新市场,使被动式承重设备转变为主动式、数据驱动的治疗系统。传统设备在患者依从性方面往往存在“盲点”,因为临床医生无法确保患者在日常活动中正确佩戴设备。而内建感测器的纺织品和穿戴式装置的出现,透过持续追踪足底温度和压力差,解决了这个难题,从而能够在溃疡形成之前及早发现发炎。这项技术革新吸引了大量投资以扩大生产规模;例如,Molnlycke Healthcare在2025年1月的新闻稿中宣布向糖尿病足溃疡管理公司Siren投资800万美元,凸显了该行业向预防性数位化监测解决方案的转变。
同时,在临床对更佳解剖学贴合度的需求驱动下,采用积层製造技术的客製化承重解决方案正迅速从利基原型製作走向大规模市场生产。与标准现成产品不同,3D列印矫正器具和鞋垫是根据患者足部的精确数位扫描资料製作而成,能够实现可变刚度区域,从而优化压力重新分布,同时保持舒适性。这种客製化直接解决了因设备不合脚而导致的依从性问题,并在医疗製造领域获得了显着的经济效益。这一趋势也体现在行业业绩中,Materialze NV在2025年2月发布的「2024年第四季及全年」财务报告中显示,其医疗收入年增14.8%。这证实了全球对患者客製化3D列印医疗解决方案的需求日益增长。
The Global Offloading Devices Market is projected to expand from USD 11.01 Billion in 2025 to USD 15.28 Billion by 2031, reflecting a CAGR of 5.61%. These specialized therapeutic tools are engineered to redistribute physical pressure away from vulnerable plantar regions, playing a crucial role in healing diabetic foot ulcers and preventing lower limb amputations. By transferring weight-bearing forces to healthy areas of the foot, instruments such as total contact casts, removable cast walkers, and modified footwear provide essential protection. The market's growth is anchored by the rising global prevalence of chronic metabolic disorders, which correlates directly with increased ulcer incidence. According to the International Diabetes Federation, approximately 589 million adults were living with diabetes worldwide in 2024. This expanding patient population, alongside an aging demographic prone to neuropathy and peripheral vascular disease, drives a consistent demand for effective pressure modulation therapies.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 11.01 Billion |
| Market Size 2031 | USD 15.28 Billion |
| CAGR 2026-2031 | 5.61% |
| Fastest Growing Segment | Diabetic Foot Ulcer Management |
| Largest Market | North America |
However, market expansion faces a substantial obstacle in the form of patient non-compliance with prescribed mechanical offloading protocols. Despite their clinical effectiveness, many devices are viewed by patients as burdensome, physically restrictive, or aesthetically undesirable, which often leads to early discontinuation of usage. This lack of adherence frequently results in the recurrence of ulcers and extended recovery periods, thereby complicating clinical outcomes. Consequently, these challenges negatively influence the broader acceptance and implementation of strict offloading regimens within standard medical care pathways.
Market Driver
The primary force propelling market momentum is the escalating global prevalence of diabetes and diabetic foot ulcers. Chronic hyperglycemia significantly impairs peripheral nerve function and vascular health, increasing susceptibility to plantar lesions and necessitating mechanical offloading to alleviate peak pressure and support tissue repair. This clinical necessity is highlighted by the substantial risk of ulceration among diabetic individuals. As noted by the American Diabetes Association in 'Standards of Care in Diabetes-2025' released in December 2024, the lifetime risk of developing a foot ulcer for a person with diabetes falls between 19% and 34%, emphasizing the urgent need for effective pressure modulation therapies to prevent severe outcomes such as amputation.
Simultaneously, the rising incidence of obesity-induced musculoskeletal complications further intensifies the demand for robust therapeutic solutions. Excessive body mass places supraphysiological stress on foot structures, which accelerates tissue breakdown and hinders the healing of existing wounds. This demographic trend represents a vast addressable market, with the World Obesity Federation's 'World Obesity Atlas 2024' reporting in March 2024 that over one billion people globally are living with obesity. This growing patient base directly impacts industry performance, as manufacturers witness continued interest in weight-bearing aids. For example, Ossur's 'Interim Report Q4 2023' from January 2024 noted that its Bracing & Supports segment, which includes key offloading technologies, achieved 3% organic sales growth in fiscal year 2023, illustrating the steady integration of these devices into standard treatment protocols.
Market Challenge
A significant barrier to the growth of the Global Offloading Devices Market is patient non-compliance with prescribed mechanical offloading protocols. While these mechanisms are vital for pressure redistribution, their designs often favor functional efficacy over user comfort, resulting in considerable resistance from patients. When individuals find the devices cumbersome or restrictive, they frequently stop using them before the treatment is complete, which interrupts necessary tissue repair and leads to extended recovery times and lower clinical success rates. As a result, the market is impacted because the real-world effectiveness of these devices falls short of their theoretical potential, thereby reducing confidence in strict offloading regimens.
This gap in adherence impedes market development by increasing long-term complication rates, which makes the economic justification for these therapies within standard care pathways more difficult. The persistent failure to heal caused by non-use leads to severe consequences that negatively affect adoption rates. According to the Society of Tissue Viability in 2024, recurrence rates following diabetic foot ulcer healing ranged from 6.2% to 41.4%. These figures highlight a critical disconnect between the prescription of devices and their actual usage, demonstrating how non-compliance directly reduces the effective reach and commercial expansion of the offloading market.
Market Trends
The integration of smart sensor technology for continuous pressure monitoring is fundamentally transforming the market by evolving passive offloading instruments into active, data-driven therapeutic systems. Traditional devices often suffer from a "blind spot" regarding patient adherence, as clinicians cannot confirm if the mechanism is worn correctly during daily life. Emerging sensor-embedded textiles and wearables solve this by continuously tracking plantar temperature and pressure differences, allowing for the early detection of inflammation before ulcers develop. This technological evolution is drawing substantial investment to scale production; for instance, Molnlycke Health Care announced in a January 2025 press release an investment of USD 8 million in the diabetic foot ulcer management company Siren, highlighting the industry's shift toward preventative digital monitoring solutions.
Concurrently, the adoption of additive manufacturing for personalized offloading solutions is rapidly transitioning from niche prototyping to mass-market fabrication, driven by the clinical demand for superior anatomical fit. Unlike standard off-the-shelf options, 3D-printed orthotics and insoles are created from precise digital scans of a patient's foot, enabling variable stiffness zones that optimize pressure redistribution while maintaining comfort. This customization directly addresses non-compliance issues stemming from ill-fitting devices and is gaining significant economic traction in the medical manufacturing sector. This trend is reflected in industrial performance, with Materialise NV reporting in its 'Fourth Quarter and Full Year 2024 Results' in February 2025 that revenue from its Medical segment increased by 14.8% year-over-year, underscoring the rising global demand for patient-specific, 3D-printed medical solutions.
Report Scope
In this report, the Global Offloading Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Offloading Devices Market.
Global Offloading Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: